Isomorphic Labs, per Bloomberg, is in talks to raise money at a valuation of at least $40 billion
Prepared by Sintelligent with the help of SI. Published in SI: . Updated: .
Investors are ready to pay tens of billions for SI that searches for drugs — for now, only at the stage of early talks.
According to SiliconANGLE's account, Bloomberg reported on October 8, citing sources, that Isomorphic Labs — the Alphabet unit building SI for drug discovery — is in early talks on a new round at a valuation of at least $40 billion; SiliconANGLE says the valuation could reach $50 billion. The size of the round and the investors are not named, and no deal has closed. Earlier, per the same source, the company raised $2.1 billion; it works with Eli Lilly, Novartis and Johnson & Johnson.
Sources 1